Moexipril Hydrochloride
C27H34N2O7·HCl
535.03
3-Isoquinolinecarboxylic acid, 2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, monohydrochloride, [3S-[2[R*(R*)],3R*]]-;
(3S)-2-[(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester, monohydrochloride [82586-52-5]
3-Isoquinolinecarboxylic acid, 2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, monohydrochloride, [3S-[2[R*(R*)],3R*]]-;
(3S)-2-[(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester, monohydrochloride [82586-52-5]
DEFINITION
Moexipril Hydrochloride contains NLT 98.0% and NMT 102.0% of moexipril hydrochloride (C27H34N2O7·HCl), calculated on the anhydrous basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Imidazole RSUSP Moexipril Hydrochloride RS
USP Moexipril Related Compound A RS
USP Moexipril Related Compound B RS
USP Moexipril Related Compound C RS
USP Moexipril Related Compound D RS
USP Moexipril Related Compound E RS
USP Moexipril Related Compound F RS
USP Moexipril Related Compound G RS